Search by Drug Name or NDC

    NDC 51248-0250-99 VESIcare 1 mg/mL Details

    VESIcare 1 mg/mL

    VESIcare is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is SOLIFENACIN SUCCINATE.

    Product Information

    NDC 51248-0250
    Product ID 51248-250_1b2e74b9-d2ab-4394-ac49-32208aae8751
    Associated GPIs 54100055201820
    GCN Sequence Number 080587
    GCN Sequence Number Description solifenacin succinate ORAL SUSP 1 MG/ML ORAL
    HIC3 R1I
    HIC3 Description URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG.
    GCN 47476
    HICL Sequence Number 026595
    HICL Sequence Number Description SOLIFENACIN SUCCINATE
    Brand/Generic Brand
    Proprietary Name VESIcare
    Proprietary Name Suffix LS
    Non-Proprietary Name solifenacin succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 1
    Active Ingredient Units mg/mL
    Substance Name SOLIFENACIN SUCCINATE
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209529
    Listing Certified Through 2024-12-31

    Package

    NDC 51248-0250-99 (51248025099)

    NDC Package Code 51248-250-99
    Billing NDC 51248025099
    Package 1 BOTTLE, PLASTIC in 1 CARTON (51248-250-99) / 150 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2020-05-26
    NDC Exclude Flag N
    Pricing Information N/A